These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 6197163)

  • 41. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.
    Zhang S; Zhang HS; Reuter VE; Slovin SF; Scher HI; Livingston PO
    Clin Cancer Res; 1998 Feb; 4(2):295-302. PubMed ID: 9516914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
    Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
    Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
    Obata N; Kodama S; Hando T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas.
    Bodey B; Bodey B; Kaiser HE
    Anticancer Res; 1997; 17(3C):2343-6. PubMed ID: 9216712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
    Yu DS; Hsieh DS; Chen HI; Chang SY
    J Urol; 2001 Sep; 166(3):871-5. PubMed ID: 11490236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
    Crawford ED; DeAntoni EP; Ross CA
    J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-linking of the carcinoembryonic antigen-like glycoproteins CD66 and CD67 induces neutrophil aggregation.
    Kuijpers TW; van der Schoot CE; Hoogerwerf M; Roos D
    J Immunol; 1993 Nov; 151(9):4934-40. PubMed ID: 8104998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
    Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M
    Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces.
    Kuroki M; Koga Y; Matsuoka Y
    Cancer Res; 1981 Feb; 41(2):713-20. PubMed ID: 6160910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human chorionic gonadotropin in lung and lung tumors. Immunohistochemical study on unbalanced distribution of subunits.
    Fukayama M; Hayashi Y; Koike M; Hajikano H; Endo S; Okumura H
    Lab Invest; 1986 Oct; 55(4):433-43. PubMed ID: 2429065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
    Dema A; Tudose N
    Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT; Yazdi HM; Farmer J
    Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors.
    Papotti M; Paties C; Peveri V; Moscuzza L; Bussolati G
    Basic Appl Histochem; 1989; 33(1):25-9. PubMed ID: 2471501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.